Hypertension is a worldwide public-health challenge because of the high prevalence and its contribution to the burden of heart disease, stroke and renal failure. Choosing the right antihypertensive drug for an individual patient requires understanding of the factors contributing to variability in high blood pressure (BP) and to the variability in drug response both between and within individuals over time. Petra van Rijn-Bikker throws light on how individual patients respond to antihypertensive medication and how this variation can be accounted for (e.g. ethnicity and genes).
P.C. Van Rijn-Bikker, Variability in Response to Antihypertensive Drug Therapy: From Population Based Therapy towards Individualized Treatment.
Prof. R.A.A. Mathôt
Prof. R.P. Koopmans (Maastricht UMC)
Dr R.M. van Hest
This event is open to the public.